Literature DB >> 24731681

Acute hyperammonemic encephalopathy in a non-cirrhotic patient with hepatocellular carcinoma reversed by arginine therapy.

Shivani S Shinde1, Prashant Sharma2, Mellar P Davis3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24731681     DOI： 10.1016/j.jpainsymman.2014.01.002

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  5 in total

1.  Chemotherapy in a Breast Cancer Patient Heterozygous Carrier of Ornithine Transcarbamylase Deficiency.

Authors:  Magda Palka-Kotlowska; Luis Cabezón-Gutiérrez; Sara Custodio-Cabello; PIlar Quijada-Fraile; Silvia Chumillas-Calzada
Journal:  Cureus       Date:  2020-05-26

2.  Hyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review.

Authors:  Janice Cho; Joy C Y Chen; Jonas Paludo; Erin E Conboy; Brendan C Lanpher; Steven R Alberts; Thorvardur R Halfdanarson
Journal:  J Gastrointest Oncol       Date:  2019-06

3.  Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.

Authors:  Claudia I Chapuy; Inderneel Sahai; Rohit Sharma; Andrew X Zhu; Olga N Kozyreva
Journal:  Oncologist       Date:  2016-03-14

4.  Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma.

Authors:  Nimish Thakral; Douglas A Simonetto
Journal:  Clin Mol Hepatol       Date:  2019-08-16

5.  Sunitinib-associated hyperammonemic encephalopathy successfully managed with higher intensity conventional hemodialysis: A case report.

Authors:  Sabrina Haroon; Stephanie Ko; Alvin Wong; Poh-Seng Tan; Evan Lee; Titus Lau
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.